ALS Limited logo

ALS Limited (CP4)

Market Closed
12 Dec, 20:00
XFRA XFRA
12. 10
+0.3
+2.54%
- Market Cap
- P/E Ratio
0.56% Div Yield
300 Volume
- Eps
11.8
Previous Close
Day Range
12.1 12.1
Year Range
7.6 12.5
Want to track CP4 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CP4 closed yesterday higher at €12.1, an increase of 2.54% from Thursday's close, completing a monthly increase of 0% or €0. Over the past 12 months, CP4 stock gained 35.96%.
CP4 pays dividends to its shareholders, with the most recent payment made on Jul 25, 2025. The next announced payment will be in In 3 days on Dec 17, 2025 for a total of €0.194.
The last earnings report, released on Nov 18, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ASX (AUD).

CP4 Chart

ALS Limited (CP4) FAQ

What is the stock price today?

The current price is €12.10.

On which exchange is it traded?

ALS Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is CP4.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.56%.

What is its market cap?

As of today, no market cap data is available.

Has ALS Limited ever had a stock split?

No, there has never been a stock split.

ALS Limited Profile

Metals & Mining Industry
Materials Sector
Mr. Malcolm Deane CEO
XFRA Exchange
AU000000ALQ6 ISIN
AU Country
19,565 Employees
26 Nov 2025 Last Dividend
2 Aug 2012 Last Split
- IPO Date

Overview

ALS Limited is an established provider of professional technical services, with a primary focus on testing, measurement, and inspection across a global footprint that encompasses Africa, Asia/Pacific, Europe, the Middle East, and the Americas. Founded in 1863 and with its headquarters in Brisbane, Australia, the company operates within two main segments: Commodities and Life Sciences. Through its global network, ALS Limited offers a comprehensive range of technical services designed to meet the needs of a variety of industries, including mining, environmental protection, food production, pharmaceuticals, and consumer products. The firm's extensive experience and technological expertise enable it to support clients throughout the entire lifecycle of their projects, providing critical data and insights that drive decision-making and performance improvement.

Products and Services

  • Commodities

    This segment offers an array of services primarily to the mining and mineral exploration sector. Services include assaying, analytical testing, metallurgical services, and a host of others tailored to support the entire resource life cycle. Key offerings comprise exploration support, feasibility studies, optimization, production enhancement, design and development assistance, trade services, and rehabilitation consulting. Moreover, ALS Limited provides specialized coal sampling, analysis, and certification, along with formation evaluation and various other analytical testing services to elevate the operational efficiency and sustainability of mining operations.

  • Life Sciences

    Targeting environmental, food, pharmaceutical, and consumer products markets, the Life Sciences segment delivers comprehensive analytical testing and sampling, alongside remote monitoring services. It focuses on providing essential data for microbiological, physical, and chemical testing. The variety of services offered meets the needs of consulting and engineering firms, diverse industries, and governmental agencies, facilitating them in ensuring compliance, maintaining quality standards, and advancing public health and safety. Analytical testing data furnished by this segment is pivotal in enabling clients to make informed, evidence-based decisions regarding their operations and product offerings.

Contact Information

Address: 299 Coronation Drive
Phone: 61 7 3367 7900